17-43768035-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004090.4(DUSP3):c.*1574G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.663 in 152,082 control chromosomes in the GnomAD database, including 34,389 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.66 ( 34387 hom., cov: 32)
Exomes 𝑓: 1.0 ( 2 hom. )
Consequence
DUSP3
NM_004090.4 3_prime_UTR
NM_004090.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.777
Publications
16 publications found
Genes affected
DUSP3 (HGNC:3069): (dual specificity phosphatase 3) The protein encoded by this gene is a member of the dual specificity protein phosphatase subfamily. These phosphatases inactivate their target kinases by dephosphorylating both the phosphoserine/threonine and phosphotyrosine residues. They negatively regulate members of the mitogen-activated protein (MAP) kinase superfamily (MAPK/ERK, SAPK/JNK, p38), which are associated with cellular proliferation and differentiation. Different members of the family of dual specificity phosphatases show distinct substrate specificities for various MAP kinases, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. This gene maps in a region that contains the BRCA1 locus which confers susceptibility to breast and ovarian cancer. Although DUSP3 is expressed in both breast and ovarian tissues, mutation screening in breast cancer pedigrees and in sporadic tumors was negative, leading to the conclusion that this gene is not BRCA1. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DUSP3 | ENST00000226004.8 | c.*1574G>A | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_004090.4 | ENSP00000226004.2 | |||
| DUSP3 | ENST00000590935.1 | c.*1746G>A | 3_prime_UTR_variant | Exon 3 of 3 | 5 | ENSP00000468604.1 | ||||
| DUSP3 | ENST00000590753.1 | c.*28-1251G>A | intron_variant | Intron 3 of 3 | 5 | ENSP00000466069.1 |
Frequencies
GnomAD3 genomes AF: 0.663 AC: 100805AN: 151960Hom.: 34382 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
100805
AN:
151960
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 1.00 AC: 4AN: 4Hom.: 2 Cov.: 0 AF XY: 1.00 AC XY: 4AN XY: 4 show subpopulations
GnomAD4 exome
AF:
AC:
4
AN:
4
Hom.:
Cov.:
0
AF XY:
AC XY:
4
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
2
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
AC:
2
AN:
2
GnomAD4 genome AF: 0.663 AC: 100833AN: 152078Hom.: 34387 Cov.: 32 AF XY: 0.668 AC XY: 49667AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
100833
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
49667
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
20445
AN:
41456
American (AMR)
AF:
AC:
11528
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
2049
AN:
3470
East Asian (EAS)
AF:
AC:
4440
AN:
5174
South Asian (SAS)
AF:
AC:
3437
AN:
4824
European-Finnish (FIN)
AF:
AC:
8040
AN:
10556
Middle Eastern (MID)
AF:
AC:
189
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48612
AN:
68008
Other (OTH)
AF:
AC:
1395
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1667
3334
5000
6667
8334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2726
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.